Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030

Smoking Cessation and Nicotine De-Addiction Products Trends and Forecast

The future of the global smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets. The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030. The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

A more than 150-page report is developed to help in your business decisions.

Smoking Cessation and Nicotine De-Addiction Products by Segment

The study includes a forecast for the global smoking cessation and nicotine de-addiction products by form, product, distribution channel, and region.

Smoking Cessation and Nicotine De-Addiction Products Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Gum
• Inhaler
• Tablet
• Others

Smoking Cessation and Nicotine De-Addiction Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Nicotine Replacement Therapy Products
• Drug Therapy
• E-Cigarettes

Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Online Provider
• Drug Stores and Retail Pharmacies

Smoking Cessation and Nicotine De-Addiction Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Smoking Cessation and Nicotine De-Addiction Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smoking cessation and nicotine de-addiction products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smoking cessation and nicotine de-addiction products companies profiled in this report include-

• Pfizer
• Imperial Brands
• Njoy Company
• Glaxosmithkline
• British American Tobacco
• Perrigo Company
• Johnson And Johnson
• Rusan Pharma
• Dr. Reddy'S Laboratories
• 22nd Century

Smoking Cessation and Nicotine De-Addiction Products Market Insights

Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Within this market, online provider is expected to witness highest growth due to rapid digitalization, ease of purchase, and quicker delivery of products.

North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Features of the Global Smoking Cessation and Nicotine De-Addiction Products Market

Market Size Estimates: Smoking cessation and nicotine de-addiction products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smoking cessation and nicotine de-addiction products market size by form, product, distribution channel, and region in terms of value ($B).

Regional Analysis: Smoking cessation and nicotine de-addiction products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different forms, products, distribution channels, and regions for the smoking cessation and nicotine de-addiction products market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smoking cessation and nicotine de-addiction products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for smoking cessation and nicotine de-addiction products market?

Answer: The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smoking cessation and nicotine de-addiction products market?

Answer: The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

Q3. What are the major segments for smoking cessation and nicotine de-addiction products market?

Answer: The future of the smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets.

Q4. Who are the key smoking cessation and nicotine de-addiction products market companies?

Answer: Some of the key smoking cessation and nicotine de-addiction products companies are as follows:

• Pfizer
• Imperial Brands
• Njoy Company
• Glaxosmithkline
• British American Tobacco
• Perrigo Company
• Johnson And Johnson
• Rusan Pharma
• Dr. Reddy'S Laboratories
• 22nd Century

Q5. Which smoking cessation and nicotine de-addiction products market segment will be the largest in future?

Answer: Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Q6. In smoking cessation and nicotine de-addiction products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the smoking cessation and nicotine de-addiction products market by form (gum, inhaler, tablet, and others), product (nicotine replacement therapy products, drug therapy, and e-cigarettes), distribution channel (hospital pharmacies, online provider, and drug stores and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?